Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A fixed-dose combination dietary supplement containing **pleuran** (a beta-1,3/1,6-D-glucan polysaccharide derived from Pleurotus ostreatus), **zinc** (an essential trace element), and **vitamin D3** (cholecalciferol). Pleuran acts primarily as an **immunomodulator**, stimulating or regulating the body's immune responses. Zinc contributes to immune function, DNA synthesis, and antioxidant defense. Vitamin D3 is a fat-soluble vitamin essential for calcium metabolism, bone health, and immunoregulation. Such combinations are considered for supporting immune function and preventing or treating deficiencies, and in at least one clinical study, a similar pleuran-based combination (though typically with vitamin C rather than D3) was evaluated for reducing the frequency and duration of respiratory exacerbations in chronic obstructive pulmonary disease (COPD) patients[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pleuran + zinc + vitamin D3.